首页> 美国卫生研究院文献>other >Structure activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors
【2h】

Structure activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors

机译:吡咯坏死抑制剂的结构活性关系和肝微粒体稳定性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Necroptosis is a regulated caspase-independent cell death pathway resulting in morphology reminiscent of passive non-regulated necrosis. Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of [1,2,3]thiadiazole benzylamide derivatives. However, initial evaluation of mouse liver microsome stability indicated that this series of compounds was rapidly degraded. A structure-activity relationship (SAR) study of the [1,2,3]thiadiazole benzylamide series revealed that increased mouse liver microsome stability and increased necroptosis inhibitory activity could be accomplished by replacement of the 4-cyclopropyl-[1,2,3]thiadiazole with a 5-cyano-1-methylpyrrole. In addition, the SAR and the cellular activity profiles, utilizing different cell types and necroptosis-inducing stimuli, of representative [1,2,3]thiadiazole and pyrrole derivatives were very similar suggesting that the two compound series inhibit necroptosis in the same manner.
机译:坏死性坏死是一种受调节的与半胱天冬酶无关的细胞死亡途径,导致形态让人联想到被动性非调节性坏死。迄今为止,已经报道了几种不同结构的坏死病抑制剂,包括一系列的[1,2,3]噻二唑苄酰胺衍生物。但是,对小鼠肝微粒体稳定性的初步评估表明该系列化合物被迅速降解。对[1,2,3]噻二唑苄酰胺系列的结构-活性关系(SAR)研究表明,通过取代4-环丙基-[1,2,3],可以提高小鼠肝脏微粒体的稳定性,并增加坏死性坏死抑制活性。 ]噻二唑与5-氰基-1-甲基吡咯。另外,代表性的[1,2,3]噻二唑和吡咯衍生物利用不同的细胞类型和诱导坏死病的刺激的SAR和细胞活性概况非常相似,表明这两个化合物系列以相同的方式抑制坏死病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号